Oregovomab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | CA125 |
| Clinical data | |
| Trade names | OvaRex |
| Identifiers | |
213327-37-8  | |
| None | |
| KEGG |
D05269  |
| Chemical data | |
| ca. 150 kDa | |
| (what is this?) (verify) | |
Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer.[1]
This drug was developed by AltaRex Corp.
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Oregovomab, American Medical Association.